scispace - formally typeset
C

Christine B. Franzese

Researcher at University of Missouri

Publications -  15
Citations -  541

Christine B. Franzese is an academic researcher from University of Missouri. The author has contributed to research in topics: Omalizumab & Nasal polyps. The author has an hindex of 5, co-authored 15 publications receiving 307 citations.

Papers
More filters
Journal ArticleDOI

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Sarah K. Wise, +71 more
TL;DR: To evaluate the existing AR literature, international multidisciplinary experts with an interest in AR have produced the International Consensus statement on Allergy and Rhinology: Allergic Rhinitis (ICAR:AR).
Journal ArticleDOI

The state of diversity based on race, ethnicity, and sex in otolaryngology in 2016.

TL;DR: To compare the representation of women and racial minorities among otolaryngology residents and faculty to other surgical specialties, data is collected on residents, faculty, and patients from eight major medical specialties.
Journal ArticleDOI

Targeted Molecular Therapies in Allergy and Rhinology.

TL;DR: The diagnosis and management of chronic rhinosinusitis with nasal polyps, asthma, eosinophilic granulomatosis with polyangiitis, and chronic spontaneous urticaria are summarized and the clinical trial data that has led to regulatory approval of biologic agents for these conditions are critically reviewed.
Journal ArticleDOI

Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup Analysis.

TL;DR: Broad efficacy of omalizumab across clinical and patient-reported outcomes in patients with CRSwNP is suggested, independent of the underlying patient factors examined, including those with high eosinophil levels and those who have undergone previous surgery, which are associated with high recurrence.
Journal ArticleDOI

The Role of Biologics in the Treatment of Nasal Polyps.

TL;DR: The role of biological agents in the treatment of CRSwNP as well as the patient characteristics that make suitable candidates for biologics are discussed.